Clinical Neurophysiology

The research in the clinical neurophysiology unit is translational and focuses on optimizing neurophysiological parameters for diagnosis and follow-up of diseases of the peripheral and central nervous system. We have a preclinical lab with a method for measuring detailed extracellular signals from muscle and nerve cells to better map disease mechanisms.
Our research
Our research focuses on understanding the mechanisms underlying disturbed neuronal and neuromuscular signaling and on developing novel diagnostic tools, biomarkers, and personalized treatment strategies for patients with neurological disorders.
We conduct translational research spanning advanced cellular models, molecular analyses, clinical studies, and population-based registry research. Our overarching goal is to bridge the gap between laboratory discoveries and patient care, enabling precision medicine approaches in neurology.
A major research focus is myasthenia gravis (MG), where we investigate both disease mechanisms and novel circulating biomarkers, including microRNAs, inflammatory proteins, and complement-related factors. Using human cell-based models of the neuromuscular junction, we study how pathogenic autoantibodies disrupt communication between nerves and muscles and evaluate new therapeutic strategies.
Our group also conducts research on facial nerve palsy, the neuromuscular effects of botulinum toxin, and immune-mediated mechanisms in neurological diseases. Through the FACE (Facial nerve palsy: A Comprehensive Exploration for Precision Medicine) initiative, we develop novel biomarkers and prognostic tools to improve individualized patient care.
The research group includes several clinician-scientists working on methodological development within clinical neurophysiology. These projects aim to improve the diagnosis, prognosis, and monitoring of neuromuscular disorders, including amyotrophic lateral sclerosis (ALS), myasthenia gravis, and other diseases affecting nerve and muscle function.
By integrating clinical neurophysiology, immunology, molecular biology, advanced imaging, and artificial intelligence, we strive to develop the next generation of diagnostic and therapeutic tools for neurological diseases.
Group members
Publications
-
Part of Muscle and Nerve, p. 92-102, 2026
- DOI for Digital Phenotyping and Lifestyle Intervention in Patients With Myasthenia Gravis (DIG-MG): A Randomized Controlled Trial of Feasibility, Adherence, and Effects on Fatigue
- Download full text (pdf) of Digital Phenotyping and Lifestyle Intervention in Patients With Myasthenia Gravis (DIG-MG): A Randomized Controlled Trial of Feasibility, Adherence, and Effects on Fatigue
-
Long-term neuromuscular alterations during botulinum toxin treatment for chronic migraine
Part of Clinical Neurophysiology Practice, p. 503-511, 2026
- DOI for Long-term neuromuscular alterations during botulinum toxin treatment for chronic migraine
- Download full text (pdf) of Long-term neuromuscular alterations during botulinum toxin treatment for chronic migraine
-
Part of eBioMedicine, 2026
- DOI for Serum inflammatory proteomic signatures define chronic inflammatory demyelinating polyneuropathy and inform on disease activity
- Download full text (pdf) of Serum inflammatory proteomic signatures define chronic inflammatory demyelinating polyneuropathy and inform on disease activity
-
Risk of Myasthenia Gravis Exacerbation During Pregnancy and Postpartum A Nationwide Cohort Study
Part of Neurology, 2026
- DOI for Risk of Myasthenia Gravis Exacerbation During Pregnancy and Postpartum A Nationwide Cohort Study
- Download full text (pdf) of Risk of Myasthenia Gravis Exacerbation During Pregnancy and Postpartum A Nationwide Cohort Study
-
Complement C3 Inhibition Restores Myasthenia Gravis AChR Antibody-Mediated Muscle Pathophysiology
Part of eBioMedicine, 2026
- DOI for Complement C3 Inhibition Restores Myasthenia Gravis AChR Antibody-Mediated Muscle Pathophysiology
- Download full text (pdf) of Complement C3 Inhibition Restores Myasthenia Gravis AChR Antibody-Mediated Muscle Pathophysiology
-
Part of Journal of Neuroimmunology, 2026
- DOI for Targeted Proteomic Profiling of Serum and CSF Reveals CASP-8 as a Candidate Biomarker in anti-NMDAR Encephalitis
- Download full text (pdf) of Targeted Proteomic Profiling of Serum and CSF Reveals CASP-8 as a Candidate Biomarker in anti-NMDAR Encephalitis
-
On the road to blood biomarkers in myasthenia gravis (MG): Beyond clinical scales
Part of Journal of Neuromuscular Diseases, p. 493-506, 2026
- DOI for On the road to blood biomarkers in myasthenia gravis (MG): Beyond clinical scales
- Download full text (pdf) of On the road to blood biomarkers in myasthenia gravis (MG): Beyond clinical scales
-
Part of European Journal of Neurology, 2025
- DOI for Rituximab in New-Onset Generalized Myasthenia Gravis: Long-Term Follow-Up of the RINOMAX Clinical Trial
- Download full text (pdf) of Rituximab in New-Onset Generalized Myasthenia Gravis: Long-Term Follow-Up of the RINOMAX Clinical Trial
-
Part of European Journal of Neurology, 2025
- DOI for AXIN1, STAMBP, ST1A1, CDCP1, and SIRT2 Validated as Myasthenia Gravis Biomarkers: A Comparative Proteomic Study With MS, CIDP, and Controls
- Download full text (pdf) of AXIN1, STAMBP, ST1A1, CDCP1, and SIRT2 Validated as Myasthenia Gravis Biomarkers: A Comparative Proteomic Study With MS, CIDP, and Controls
-
Exploring rituximab for the treatment of refractory myasthenia gravis: a single-centre experience
Part of BMJ NEUROLOGY OPEN, 2025
- DOI for Exploring rituximab for the treatment of refractory myasthenia gravis: a single-centre experience
- Download full text (pdf) of Exploring rituximab for the treatment of refractory myasthenia gravis: a single-centre experience
-
Part of Frontiers in Immunology, 2025
- DOI for Inflammatory imbalance and activation deficits in T cells of myasthenia gravis patients revealed by proteomic profiling
- Download full text (pdf) of Inflammatory imbalance and activation deficits in T cells of myasthenia gravis patients revealed by proteomic profiling
-
Part of Clinical Nuclear Medicine, p. 208-213, 2025
-
Part of Muscle and Nerve, p. 851-861, 2024
- DOI for Visualization and characterization of complement activation in acetylcholine receptor antibody seropositive myasthenia gravis
- Download full text (pdf) of Visualization and characterization of complement activation in acetylcholine receptor antibody seropositive myasthenia gravis
-
Part of Brain and Behavior, 2024
- DOI for Antibody-positive autoimmune encephalitis and paraneoplastic neurological syndrome: A Swedish case series
- Download full text (pdf) of Antibody-positive autoimmune encephalitis and paraneoplastic neurological syndrome: A Swedish case series
-
Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment
Part of European Journal of Neurology, 2024
- DOI for Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment
- Download full text (pdf) of Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment
-
Elevated C1s/C1-INH in serum and plasma of myasthenia gravis patients
Part of Journal of Neuroimmunology, 2024
- DOI for Elevated C1s/C1-INH in serum and plasma of myasthenia gravis patients
- Download full text (pdf) of Elevated C1s/C1-INH in serum and plasma of myasthenia gravis patients
-
Part of iScience, p. 110564, 2024
- DOI for Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controls.
- Download full text (pdf) of Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controls.
-
Short-term changes in serum miRNA levels and patient-reported clinical outcomes in myasthenia gravis
Part of Muscle and Nerve, p. 284-289, 2024
- DOI for Short-term changes in serum miRNA levels and patient-reported clinical outcomes in myasthenia gravis
- Download full text (pdf) of Short-term changes in serum miRNA levels and patient-reported clinical outcomes in myasthenia gravis
-
Part of European Journal of Neurology, 2024
- DOI for Pregnancy outcomes for women with myasthenia gravis and their newborns: A nationwide register-based cohort study
- Download full text (pdf) of Pregnancy outcomes for women with myasthenia gravis and their newborns: A nationwide register-based cohort study
-
Functional imaging of conduction dynamics in cortical and spinal axons
Part of eLIFE, 2023
- DOI for Functional imaging of conduction dynamics in cortical and spinal axons
- Download full text (pdf) of Functional imaging of conduction dynamics in cortical and spinal axons
-
Keeping up appearances: Don't frown upon the effects of botulinum toxin injections in facial muscles
Part of Clinical Neurophysiology Practice, p. 169-173, 2023
- DOI for Keeping up appearances: Don't frown upon the effects of botulinum toxin injections in facial muscles
- Download full text (pdf) of Keeping up appearances: Don't frown upon the effects of botulinum toxin injections in facial muscles
-
Part of Acta Neurologica Scandinavica, 2023
- DOI for Antibody-Positive Autoimmune Encephalitis and Paraneoplastic Neurological Syndrome: Epidemiology and Outcome of Neuronal Antibody Testing in Sweden
- Download full text (pdf) of Antibody-Positive Autoimmune Encephalitis and Paraneoplastic Neurological Syndrome: Epidemiology and Outcome of Neuronal Antibody Testing in Sweden
-
Part of European Journal of Neurology, p. 266-282, 2023
- DOI for Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal
- Download full text (pdf) of Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal
-
Part of Neuromuscular Disorders, p. 334-338, 2023
- DOI for Implementation of tailored exercise programs for MG patients in a gym setting: a pragmatic feasibility case study
- Download full text (pdf) of Implementation of tailored exercise programs for MG patients in a gym setting: a pragmatic feasibility case study
-
Part of JAMA Neurology, p. 1105-1112, 2022
-
Enrichment of serum IgG4 in MuSK myasthenia gravis patients
Part of Journal of Neuroimmunology, 2022
- DOI for Enrichment of serum IgG4 in MuSK myasthenia gravis patients
- Download full text (pdf) of Enrichment of serum IgG4 in MuSK myasthenia gravis patients
-
Part of Advanced Functional Materials, 2022
-
Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders
Part of Lancet Neurology, p. 176-188, 2022
-
Part of Cells, 2022
- DOI for Towards Personalized Medicine in Myasthenia Gravis: Role of Circulating microRNAs miR-30e-5p, miR-150-5p and miR-21-5p
- Download full text (pdf) of Towards Personalized Medicine in Myasthenia Gravis: Role of Circulating microRNAs miR-30e-5p, miR-150-5p and miR-21-5p
-
Novel pathogenic ALG2 mutation causing congenital myasthenic syndrome: A case report
Part of Neuromuscular Disorders, p. 80-83, 2022
- DOI for Novel pathogenic ALG2 mutation causing congenital myasthenic syndrome: A case report
- Download full text (pdf) of Novel pathogenic ALG2 mutation causing congenital myasthenic syndrome: A case report
-
Part of European Journal of Neurology, p. 1706-1715, 2021
- DOI for Cancer in myasthenia gravis subtypes in relation to immunosuppressive treatment and acetylcholine receptor antibodies: A Swedish nationwide register study
- Download full text (pdf) of Cancer in myasthenia gravis subtypes in relation to immunosuppressive treatment and acetylcholine receptor antibodies: A Swedish nationwide register study
-
Part of Clinical Neurophysiology, p. 1733-1740, 2021
- DOI for Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study
- Download full text (pdf) of Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study
-
Epidemiology of Myasthenia Gravis in Sweden 2006-2016
Part of Brain and Behavior, 2020
- DOI for Epidemiology of Myasthenia Gravis in Sweden 2006-2016
- Download full text (pdf) of Epidemiology of Myasthenia Gravis in Sweden 2006-2016
-
Part of Clinical Neurophysiology Practice, p. 46-49, 2020
- DOI for Botulinum toxin injections associated with suspected myasthenia gravis: An underappreciated cause of MG-like clinical presentation
- Download full text (pdf) of Botulinum toxin injections associated with suspected myasthenia gravis: An underappreciated cause of MG-like clinical presentation
-
Mortality rates and causes of death in Swedish Myasthenia Gravis patients
Part of Neuromuscular Disorders, p. 815-824, 2020
- DOI for Mortality rates and causes of death in Swedish Myasthenia Gravis patients
- Download full text (pdf) of Mortality rates and causes of death in Swedish Myasthenia Gravis patients
-
Myasthenia gravis patient and physician opinions about immunosuppressant reduction
Part of Muscle and Nerve, p. 767-772, 2020
-
Myasthenia Gravis and Physical Exercise: A Novel Paradigm
Part of Frontiers in Neurology, 2020
- DOI for Myasthenia Gravis and Physical Exercise: A Novel Paradigm
- Download full text (pdf) of Myasthenia Gravis and Physical Exercise: A Novel Paradigm
-
Part of Frontiers in Immunology, 2020
- DOI for Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs
- Download full text (pdf) of Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs
-
Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine
Part of Frontiers in Immunology, 2020
- DOI for Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine
- Download full text (pdf) of Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine
-
miR-1933-3p is upregulated in skeletal muscles of MuSK+ EAMG mice and affects Impa1 and Mrpl27
Part of Neuroscience research, p. 46-52, 2020
-
Pattern of Habitual Physical Exercise in Myasthenia Gravis Patients
Part of JOURNAL OF NEUROMUSCULAR DISEASES, p. 85-91, 2019
-
Part of BMJ Open, 2019
- DOI for Study protocol for a randomised controlled trial with clinical, neurophysiological, laboratory and radiological outcome for surgical versus non-surgical treatment for lumbar spinal stenosis: the Uppsala Spinal Stenosis Trial (UppSten)
- Download full text (pdf) of Study protocol for a randomised controlled trial with clinical, neurophysiological, laboratory and radiological outcome for surgical versus non-surgical treatment for lumbar spinal stenosis: the Uppsala Spinal Stenosis Trial (UppSten)
-
Cognitive dysfunction in mice with passively induced MuSK antibody seropositive myasthenia gravis
Part of Journal of the Neurological Sciences, p. 15-21, 2019
-
Facing the challenges of electrodiagnostic studies in the very elderly (>80 years) population
Part of Clinical Neurophysiology, p. 1091-1097, 2019
-
miR-30e-5p as predictor of generalization in ocular myasthenia gravis
Part of Annals of clinical and translational neurology, p. 243-251, 2019
- DOI for miR-30e-5p as predictor of generalization in ocular myasthenia gravis
- Download full text (pdf) of miR-30e-5p as predictor of generalization in ocular myasthenia gravis
-
Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum
Part of Scientific Reports, 2019
- DOI for Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum
- Download full text (pdf) of Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum
-
Circulating microRNA plasma profile in MuSK plus myasthenia gravis
Part of Journal of Neuroimmunology, p. 87-91, 2018
-
Advances in autoimmune myasthenia gravis management
Part of Expert Review of Neurotherapeutics, p. 573-588, 2018
-
Long-Term High-Density Extracellular Recordings Enable Studies of Muscle Cell Physiology
Part of Frontiers in Physiology, 2018
- DOI for Long-Term High-Density Extracellular Recordings Enable Studies of Muscle Cell Physiology
- Download full text (pdf) of Long-Term High-Density Extracellular Recordings Enable Studies of Muscle Cell Physiology
-
Part of Journal of Neuroimmunology, p. 164-170, 2018
- DOI for Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis
- Download full text (pdf) of Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis
Student Projects
We welcome highly motivated BSc, MSc, and medical students interested in:
- Biomarker discovery in autoimmune neurological disorders
- Functional immune profiling
- Human neuromuscular junction models
- Stem cell-derived neuronal systems
- Machine learning and biomarker prediction
- Clinical neurophysiology and precision medicine
Interested students are encouraged to contact the research group for available projects.